BOSTON, Jan. 21, 2025 /PRNewswire/ -- Antennova, a clinical-stage biotech company focused on oncolo...
* In patients with non-small cell lung cancer (NSCLC) or melanoma who had acquired resistance to...
BOSTON, Sept. 8, 2024 /PRNewswire/ -- Antennova, a clinical-stage biotech company focused on oncolo...
BOSTON, Aug. 5, 2024 /PRNewswire/ -- Antennova, a clinical-stage biotech company focused on oncolog...
* ATN-031 (also known as ATG-031), is the first anti-CD24 antibody to advance to the clinic in on...